Operating Income
$1.50B
TTM · Period ending: · USD

RPRX Operating Income
What is operating income?
Operating income is profit from the core business after operating costs, before interest and income taxes.
Compare operating income
RPRX operating income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Operating Income (USD) | Change |
|---|---|---|
| 1,559,518,000 | +20.66% | |
| 1,292,444,000 | −13.38% | |
| 1,492,150,000 | +385.94% | |
| 307,065,000 | −78.54% | |
| 1,430,715,000 | −10.32% | |
| 1,595,399,000 | −39.18% | |
| 2,623,176,000 | +92.25% | |
| 1,364,446,000 | +45.20% | |
| 939,692,000 | +29.99% | |
| 722,874,000 | −8.99% | |
| 794,278,000 | — |
Frequently asked questions: RPRX operating income
What is Royalty Pharma plc (RPRX)'s current operating income?
Royalty Pharma plc (RPRX)'s latest reported operating income (TTM) is $1.50B as of Sep 30, 2026. Operating income is profit from the core business after operating costs, before interest and income taxes.
How much historical operating income data is available for RPRX?
Stock Alarm Pro provides 11 dated annual fiscal periods observations for Royalty Pharma plc (RPRX)'s operating income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare RPRX's operating income to peers or set an alert?
You can compare RPRX's operating income directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on RPRX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance